These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets. Larsson M, Vorrsjö E, Talmud P, Lookene A, Olivecrona G. J Biol Chem; 2013 Nov 22; 288(47):33997-34008. PubMed ID: 24121499 [Abstract] [Full Text] [Related]
4. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. J Biol Chem; 1990 Mar 15; 265(8):4266-72. PubMed ID: 2307668 [Abstract] [Full Text] [Related]
7. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding. MacPhee CE, Hatters DM, Sawyer WH, Howlett GJ. Biochemistry; 2000 Mar 28; 39(12):3433-40. PubMed ID: 10727238 [Abstract] [Full Text] [Related]
8. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr. Liu H, Labeur C, Xu CF, Ferrell R, Lins L, Brasseur R, Rosseneu M, Weiss KM, Humphries SE, Talmud PJ. J Lipid Res; 2000 Nov 28; 41(11):1760-71. PubMed ID: 11060345 [Abstract] [Full Text] [Related]
9. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach. Reimund M, Wolska A, Risti R, Wilson S, Sviridov D, Remaley AT, Lookene A. Biochem Biophys Res Commun; 2019 Oct 29; 519(1):67-72. PubMed ID: 31477272 [Abstract] [Full Text] [Related]
15. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism. Shirai K, Fitzharris TJ, Shinomiya M, Muntz HG, Harmony JA, Jackson RL, Quinn DM. J Lipid Res; 1983 Jun 29; 24(6):721-30. PubMed ID: 6688442 [Abstract] [Full Text] [Related]
16. Activation of lipoprotein lipase by N-alpha-palmitoyl (56-79) fragment of apolipoprotein C-II. Balasubramaniam A, Rechtin A, McLean LR, Jackson RL, Demel RA. Biochem Biophys Res Commun; 1986 Jun 30; 137(3):1041-8. PubMed ID: 3729948 [Abstract] [Full Text] [Related]
17. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides. Wolska A, Lo L, Sviridov DO, Pourmousa M, Pryor M, Ghosh SS, Kakkar R, Davidson M, Wilson S, Pastor RW, Goldberg IJ, Basu D, Drake SK, Cougnoux A, Wu MJ, Neher SB, Freeman LA, Tang J, Amar M, Devalaraja M, Remaley AT. Sci Transl Med; 2020 Jan 29; 12(528):. PubMed ID: 31996466 [Abstract] [Full Text] [Related]
18. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Sun HY, Lin CC, Lee JC, Wang SW, Cheng PN, Wu IC, Chang TT, Lai MD, Shieh DB, Young KC. Gut; 2013 Aug 29; 62(8):1193-203. PubMed ID: 22689516 [Abstract] [Full Text] [Related]
19. Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL. Larsson M, Allan CM, Jung RS, Heizer PJ, Beigneux AP, Young SG, Fong LG. J Lipid Res; 2017 Sep 29; 58(9):1893-1902. PubMed ID: 28694296 [Abstract] [Full Text] [Related]